Data from the Systemic Lupus International Collaborating Clinics (SLICC) Registry for Atherosclerosis inception cohort, concerning 1494 recently diagnosed SLE, demonstrated that MeS was present at enrollment visit in 16% of patients suggesting that lupus-related inflammatory factors could facilitate insulin-resistance and MeS development. This evidence concerns the gene INS and systemic lupus erythematosus.